Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral propranolol to prevent progression of retinopathy of prematurity in very low birth weight preterm infants
ISRCTN80067433Phase 2Completed
- Sponsor
- Universidad de Concepción
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of propranolol in retinopathy of prematurity (ROP) (2 arms), sponsored by Universidad de Concepción. Primary endpoint: Progression to treatment-requiring retinopathy of prematurity. Started Jul 2014; status: completed.
02
Drugs
propranolol
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on ISRCTN80067433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN80067433.